Fundraising Fox
CVRx
NASDAQ: CVRXAustin, US · Founded 2001 · Delaware corporation · 261 employees on LinkedIn · 8 known investors
Find your way into CVRx
Sign up to see every warm intro you have to CVRx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CVRx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
Founders & leadership
Investors · 8
How we know: ABS Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Treo Ventures, Llc's portfolio page · Not right? Tell us
How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$125.3M disclosed across 2 of 3 rounds · 2016–2020
▶$50MraisedJul 2020 · 21 investors · Other Health CareRule 506(b)
- John BrintnallExecutive Officer
- Elizabeth GalleExecutive Officer
- Dean Bruhn-DingExecutive Officer
- Kirk NielsenDirector
- Ali BehbahaniDirector
- Kadir KadhiresanDirector
- Mudit K. JainDirector
- Joseph SlatteryDirector
- Nadim YaredExecutive Officer, Director
- Geoff PardoDirector
- John M. NehraDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$75.3MraisedMay 2019 · 20 investors · Other Health CareRule 506(b)
- Craig PalmerExecutive Officer
- Geoff PardoDirector
- Nadim YaredExecutive Officer, Director
- Dean Bruhn-DingExecutive Officer
- John BrintnallExecutive Officer
- Liz GalleExecutive Officer
- John M. NehraDirector
- Kadir KadhiresanDirector
- Ali BehbahaniDirector
- Joseph SlatteryDirector
- Tom HeymanDirector
- Offering amount
- $93M
- Amount sold
- $75.3M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through CVRx went on to found or lead other companies.
Related companies · 1
Companies working in the same space as CVRx.
Frequently asked questions
- What does CVRx do?
- CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
- Who are CVRx's investors?
- CVRx's investors include ABS Ventures, New Enterprise Associates (NEA), Treo Ventures, Llc, Windham Capital Partners, Ysios Capital, Action Potential Venture Capital Ltd., Hatteras Venture Partners, Vensana Capital.
- How much funding has CVRx raised?
- CVRx has disclosed $125.3M raised across 2 of its 3 known rounds.
- Where is CVRx headquartered?
- CVRx is headquartered in Austin, US.